ADRIAN T. DILLON - 05 Jul 2024 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Director
Signature
/s/ Delano Ladd, Attorney-in-Fact
Issuer symbol
HQY
Transactions as of
05 Jul 2024
Net transactions value
$0
Form type
4
Filing time
09 Jul 2024, 13:22:04 UTC
Previous filing
05 Feb 2024
Next filing
30 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Award $0 +2,543 +4.6% $0.000000 57,515 05 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HQY Stock Option (right to buy) 7,632 05 Jul 2024 Common Stock 7,632 $32.50 Direct F2
holding HQY Stock Option (right to buy) 4,837 05 Jul 2024 Common Stock 4,837 $46.40 Direct F2
holding HQY Stock Option (right to buy) 4,339 05 Jul 2024 Common Stock 4,339 $50.41 Direct F2
holding HQY Stock Option (right to buy) 3,626 05 Jul 2024 Common Stock 3,626 $63.64 Direct F2
holding HQY Stock Option (right to buy) 4,012 05 Jul 2024 Common Stock 4,012 $66.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of July 5, 2025 or the date of the issuer's next annual stockholder meeting. Vested shares will be delivered to the reporting person upon vesting.
F2 The option is immediately exercisable.

Remarks:

The Power of Attorney given by Mr. Dillon was previously filed with the U.S. Securities & Exchange Commission on February 5, 2024, as an exhibit to a statement on Form 4 filed by Mr. Dillon with respect to HealthEquity, Inc. and is hereby incorporated by reference.